杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/07/19 | 2,147 | 2,168 | 2,119 | 2,153 | +4 | +0.2% | 146,200 |
2016/07/15 | 2,132 | 2,169 | 2,132 | 2,149 | +17 | +0.8% | 176,100 |
2016/07/14 | 2,111 | 2,157 | 2,110 | 2,132 | +11 | +0.5% | 146,400 |
2016/07/13 | 2,164 | 2,180 | 2,117 | 2,121 | +7 | +0.3% | 111,200 |
2016/07/12 | 2,141 | 2,151 | 2,110 | 2,114 | +9 | +0.4% | 143,100 |
2016/07/11 | 2,088 | 2,132 | 2,088 | 2,105 | +55 | +2.7% | 127,900 |
2016/07/08 | 2,087 | 2,097 | 2,048 | 2,050 | -42 | -2% | 160,300 |
2016/07/07 | 2,081 | 2,118 | 2,081 | 2,092 | +2 | +0.1% | 133,400 |
2016/07/06 | 2,061 | 2,092 | 2,045 | 2,090 | -24 | -1.1% | 216,900 |
2016/07/05 | 2,080 | 2,127 | 2,070 | 2,114 | +25 | +1.2% | 193,100 |
2016/07/04 | 2,046 | 2,107 | 2,040 | 2,089 | +22 | +1.1% | 157,800 |
2016/07/01 | 2,028 | 2,078 | 2,028 | 2,067 | +68 | +3.4% | 145,000 |
2016/06/30 | 2,040 | 2,050 | 1,994 | 1,999 | -40 | -2% | 255,400 |
2016/06/29 | 2,070 | 2,080 | 2,030 | 2,039 | -1 | ±0% | 177,100 |
2016/06/28 | 1,960 | 2,062 | 1,950 | 2,040 | +69 | +3.5% | 281,400 |
2016/06/27 | 1,903 | 1,975 | 1,903 | 1,971 | +120 | +6.5% | 166,000 |
2016/06/24 | 2,024 | 2,028 | 1,842 | 1,851 | -158 | -7.9% | 187,700 |
2016/06/23 | 2,008 | 2,018 | 1,994 | 2,009 | +3 | +0.1% | 96,200 |
2016/06/22 | 1,998 | 2,008 | 1,977 | 2,006 | -16 | -0.8% | 124,200 |
2016/06/21 | 1,988 | 2,024 | 1,968 | 2,022 | +23 | +1.2% | 120,800 |
2016/06/20 | 2,006 | 2,021 | 1,991 | 1,999 | +33 | +1.7% | 121,600 |
2016/06/17 | 2,048 | 2,070 | 1,966 | 1,966 | -62 | -3.1% | 385,300 |
2016/06/16 | 2,075 | 2,090 | 2,014 | 2,028 | -68 | -3.2% | 190,600 |
2016/06/15 | 2,046 | 2,111 | 2,040 | 2,096 | +53 | +2.6% | 255,000 |
2016/06/14 | 2,047 | 2,065 | 2,029 | 2,043 | -1 | ±0% | 267,400 |
2016/06/13 | 2,089 | 2,089 | 2,042 | 2,044 | -80 | -3.8% | 180,700 |
2016/06/10 | 2,148 | 2,154 | 2,106 | 2,124 | +5 | +0.2% | 197,300 |
2016/06/09 | 2,117 | 2,126 | 2,105 | 2,119 | +3 | +0.1% | 130,900 |
2016/06/08 | 2,095 | 2,116 | 2,085 | 2,116 | +35 | +1.7% | 166,400 |
2016/06/07 | 2,069 | 2,087 | 2,062 | 2,081 | +23 | +1.1% | 230,900 |
2016/06/06 | 2,033 | 2,062 | 2,025 | 2,058 | -3 | -0.1% | 170,200 |
2016/06/03 | 2,055 | 2,075 | 2,054 | 2,061 | +6 | +0.3% | 165,600 |
2016/06/02 | 2,070 | 2,079 | 2,048 | 2,055 | -29 | -1.4% | 257,100 |
2016/06/01 | 2,115 | 2,126 | 2,071 | 2,084 | -61 | -2.8% | 349,100 |
2016/05/31 | 2,183 | 2,186 | 2,145 | 2,145 | -46 | -2.1% | 260,500 |
2016/05/30 | 2,197 | 2,210 | 2,178 | 2,191 | +4 | +0.2% | 117,000 |
2016/05/27 | 2,198 | 2,202 | 2,185 | 2,187 | -16 | -0.7% | 146,500 |
2016/05/26 | 2,231 | 2,245 | 2,201 | 2,203 | -1 | ±0% | 190,200 |
2016/05/25 | 2,195 | 2,249 | 2,185 | 2,204 | +58 | +2.7% | 473,000 |
2016/05/24 | 2,108 | 2,173 | 2,108 | 2,146 | +38 | +1.8% | 384,100 |
2016/05/23 | 2,091 | 2,108 | 2,072 | 2,108 | +16 | +0.8% | 143,300 |
2016/05/20 | 2,057 | 2,107 | 2,056 | 2,092 | +22 | +1.1% | 200,300 |
2016/05/19 | 2,058 | 2,079 | 2,042 | 2,070 | -4 | -0.2% | 228,100 |
2016/05/18 | 2,076 | 2,099 | 2,056 | 2,074 | -2 | -0.1% | 151,000 |
2016/05/17 | 2,043 | 2,078 | 2,033 | 2,076 | +44 | +2.2% | 217,700 |
2016/05/16 | 2,049 | 2,069 | 2,024 | 2,032 | -22 | -1.1% | 239,000 |
2016/05/13 | 2,062 | 2,079 | 2,039 | 2,054 | -19 | -0.9% | 255,600 |
2016/05/12 | 2,110 | 2,122 | 2,018 | 2,073 | -76 | -3.5% | 320,600 |
2016/05/11 | 2,164 | 2,178 | 2,123 | 2,149 | -22 | -1% | 253,900 |
2016/05/10 | 2,136 | 2,185 | 2,124 | 2,171 | +28 | +1.3% | 270,400 |
2151~
2200
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム